Edward Pratt
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 15
- Diabetes Management and Research 7
- Surgery 7
- Pancreatic function and diabetes 6
- Co-authors
- Axel Haupt (16 shared papers)Kieren J. Mather (9 shared papers)Xiaosu Ma (6 shared papers)Deborah A. Robins (4 shared papers)Маниге Кониг (2 shared papers)Christof Kazda (4 shared papers)Rong Liu (1 shared paper)Sean Wharton (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (4 papers)Diabetes (2 papers)Diabetes Therapy (2 papers)Cell Metabolism (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Edward Pratt
18 papers receiving 686 citations
Edward Pratt's Hit Papers
Peers
Comparison fields: 5 of 67
- Endocrinology, Diabetes and Metabolism 516
- Pharmacology 272
- Physiology 200
- Endocrine and Autonomic Systems 38
- Surgery 144
Countries citing papers authored by Edward Pratt
This map shows the geographic impact of Edward Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Pratt more than expected).
Fields of papers citing papers by Edward Pratt
This network shows the impact of papers produced by Edward Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Pratt. The network helps show where Edward Pratt may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Pratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity Hit paper breakdown → | 2023 | 259 |
| 2 | Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes Hit paper breakdown → | 2023 | 120 |
| 3 | Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study Hit paper breakdown → | 2023 | 97 |
| 4 | 2002 | 51 | |
| 5 | 2022 | 40 | |
| 6 | 2023 | 34 | |
| 7 | 2023 | 23 | |
| 8 | Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation Hit paper breakdown → | 2025 | 18 |
| 9 | 2021 | 16 | |
| 10 | 2024 | 12 | |
| 11 | 2024 | 12 | |
| 12 | 2025 | 6 | |
| 13 | 2024 | 4 | |
| 14 | 2025 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2011 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2026 | 0 |
About Edward Pratt
Edward Pratt is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Pharmacology and Physiology, having authored 24 papers that have together received 703 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (7 papers), Pancreatic function and diabetes (6 papers), Pharmacology and Obesity Treatment (5 papers), Diet and metabolism studies (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Protein Tyrosine Phosphatases (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (516 citations), Pharmacology (272 citations), Physiology (200 citations), Endocrine and Autonomic Systems (38 citations) and Surgery (144 citations). Edward Pratt has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Axel Haupt, Kieren J. Mather, Xiaosu Ma, Deborah A. Robins, Маниге Кониг, Christof Kazda, Rong Liu, Sean Wharton, Tamer Coşkun and Thomas Blevins. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Diabetes Therapy, Cell Metabolism and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.